Elevai Price To Sales Ratio from 2010 to 2024

ELAB Stock   0.02  0  20.90%   
Elevai Labs,'s Price To Sales Ratio is decreasing over the years with slightly volatile fluctuation. Price To Sales Ratio is expected to dwindle to 10.91. Price To Sales Ratio is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing Elevai Labs,'s market cap by its total sales or revenue over a 12-month period. View All Fundamentals
 
Price To Sales Ratio  
First Reported
2010-12-31
Previous Quarter
11.48261354
Current Value
10.91
Quarterly Volatility
29.5 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Elevai Labs, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Elevai Labs,'s main balance sheet or income statement drivers, such as Depreciation And Amortization of 11.1 K, Selling General Administrative of 3.5 M or Selling And Marketing Expenses of 693.3 K, as well as many indicators such as Price To Sales Ratio of 10.91, Dividend Yield of 0.0 or PTB Ratio of 5.4. Elevai financial statements analysis is a perfect complement when working with Elevai Labs, Valuation or Volatility modules.
  
Check out the analysis of Elevai Labs, Correlation against competitors.

Latest Elevai Labs,'s Price To Sales Ratio Growth Pattern

Below is the plot of the Price To Sales Ratio of Elevai Labs, Common over the last few years. Price to Sales Ratio is figured by comparing Elevai Labs, Common stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Elevai Labs, sales, a figure that is much harder to manipulate than other Elevai Labs, Common multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. Elevai Labs,'s Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Elevai Labs,'s overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 4.21 X10 Years Trend
Slightly volatile
   Price To Sales Ratio   
       Timeline  

Elevai Price To Sales Ratio Regression Statistics

Arithmetic Mean57,001
Geometric Mean13,504
Coefficient Of Variation51.74
Mean Deviation22,792
Median71,246
Standard Deviation29,490
Sample Variance869.7M
Range71.2K
R-Value(0.69)
Mean Square Error485M
R-Squared0.48
Significance0
Slope(4,579)
Total Sum of Squares12.2B

Elevai Price To Sales Ratio History

2024 10.91
2023 11.48
2022 42.28

About Elevai Labs, Financial Statements

Elevai Labs, stakeholders use historical fundamental indicators, such as Elevai Labs,'s Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Although Elevai Labs, investors may analyze each financial statement separately, they are all interrelated. For example, changes in Elevai Labs,'s assets and liabilities are reflected in the revenues and expenses on Elevai Labs,'s income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Elevai Labs, Common. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Price To Sales Ratio 11.48  10.91 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Elevai Labs, Common offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Elevai Labs,'s financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Elevai Labs, Common Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Elevai Labs, Common Stock:
Check out the analysis of Elevai Labs, Correlation against competitors.
You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Elevai Labs,. If investors know Elevai will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Elevai Labs, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.44)
Revenue Per Share
0.168
Quarterly Revenue Growth
0.913
Return On Assets
(0.89)
Return On Equity
(3.51)
The market value of Elevai Labs, Common is measured differently than its book value, which is the value of Elevai that is recorded on the company's balance sheet. Investors also form their own opinion of Elevai Labs,'s value that differs from its market value or its book value, called intrinsic value, which is Elevai Labs,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Elevai Labs,'s market value can be influenced by many factors that don't directly affect Elevai Labs,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Elevai Labs,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Elevai Labs, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Elevai Labs,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.